Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Neurology and Therapy
Published in: Neurology and Therapy 1-2/2013

Open Access 01-12-2013 | Original Research

Quality of Life in Depressed Patients in UK Primary Care: The FINDER Study

Authors: Alan Lenox-Smith, Mark T. B. Macdonald, Catherine Reed, Andre Tylee, Robert Peveler, Deborah Quail, Hiram J. Wildgust

Published in: Neurology and Therapy | Issue 1-2/2013

Login to get access

Abstract

Objectives

To investigate the impact of depression and its treatment on health-related quality of life (HRQoL) in a naturalistic, primary care setting in the UK.

Methods

The Factors Influencing Depression Endpoints Research (FINDER) study was a European, 6-month, prospective, observational study designed to estimate HRQoL in patients with a clinical diagnosis of depression. This paper examines primary care patients recruited in the UK. HRQoL was measured at baseline and at 3 and 6 months after starting antidepressant therapy using the Short Form 36 Health Status Survey and the European Quality of Life-5 Dimensions (EQ-5D). Regression analysis was used to identify baseline and treatment variables independently and significantly associated with HRQoL. Further analyses included the effect of caseness for depression on HRQoL, the effect of moderate/severe pain at baseline on HRQoL, changes in overall pain, pain interference scores, and the use of different antidepressants by pain cohort.

Results

A total of 608 patients was recruited from 58 centres and mean HRQoL was significantly below reported population norms at baseline. Most improvement in HRQoL was seen at 3 months for EQ-5D, with small additional improvement at 6 months. Worse HRQoL outcomes at 6 months were associated with higher somatic symptoms score, duration of depression at baseline, and switching within antidepressant classes. Patients meeting the criteria for caseness for depression, or with significant pain at baseline showed less improvement in HRQoL scores at 6 months.

Conclusion

Patients presenting with depression in primary care show reduced HRQoL compared to population norms. HRQoL improves during antidepressant treatment particularly within the first 3 months. Nonpainful somatic symptoms, socioeconomic factors, depression variables and switching within antidepressant class predict poor HRQoL outcome. Pain is a common symptom in depressed patients and remains after 6 months’ treatment. Pain and somatic symptoms should be assessed in all patients with depression in primary care.
Literature
1.
WHO. Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19–22 June, 1946; signed on 22 July 1946 by the representatives of 61 states (Official Records of the World Health Organization, no. 2, p. 100) and entered into force on 7 April 1948. http://​www.​who.​int/​governance/​eb/​who_​constitution_​en.​pdf. Accessed 14 Feb 2013.
2.
Patrick DL, Erickson P. Health status and health policy: quality of life in health care evaluation and resource allocation. New York: Oxford University Press; 1993.
3.
Hays RD, Wells KB, Sherbourne CD, Rogers W, Spritzer K. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arch Gen Psychiatry. 1995;52:11–9.PubMedCrossRef
4.
Wells KB, Sherbourne CD. Functioning and utility for current health of patients with depression or chronic medical conditions in managed, primary care practices. Arch Gen Psychiatry. 1999;56:897–904.PubMedCrossRef
5.
Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA. 1989;262:914–9.PubMedCrossRef
6.
Ware JE, Kosinski M, Dewey JE. How to score version 2 of the SF-36® health survey. Lincoln: QualityMetric Incorporated; 2000.
7.
8.
Kroenke K, West SL, Swindle R, et al. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care. A randomized trial. JAMA. 2001;286:2947–55.PubMedCrossRef
9.
Miller IW, Keitner GI, Schatzberg AF, et al. The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. J Clin Psychiatry. 1998;59:608–19.PubMedCrossRef
10.
Detke MJ, Lu Y, Goldstein DJ, McNamara RK, Demitrack MA. Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression. J Psychiatr Res. 2002;36:383–90.PubMedCrossRef
11.
Dunner DL, Kwong WJ, Houser TL, Richard NE, Donahue RM, Khan ZM. Improved health-related quality of life and reduced productivity loss after treatment with bupropion sustained release: a study in patients with major depression. Prim Care Companion J Clin Psychiatry. 2001;3:10–6.PubMedCentralPubMedCrossRef
12.
Walker V, Streiner DL, Novosel S, Rocchi A, Levine MA, Dean DM. Health-related quality of life in patients with major depression who are treated with moclobemide. J Clin Psychopharmacol. 1995;15(4 Suppl. 2):60–7.
13.
Peveler R, Kendrick T, Buxton M, et al. A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine. Health Technol Assess. 2005;9:1–134.PubMed
14.
Simon GE, VonKorff M, Piccinelli M, Fullerton C, Ormel J. An international study of the relation between somatic symptoms and depression. N Engl J Med. 1999;341:1329–35.PubMedCrossRef
15.
Garcia-Cebrian A, Gandhi P, Demyttenaere K, Peveler R. The association of depression and painful physical symptoms—a review of the European literature. Eur Psychiatry. 2006;21:379–88.PubMedCrossRef
16.
Bair MJ, Robinson RL, Eckert GJ, Stang PE, Croghan TW, Kroenke K. Impact of pain on depression treatment response in primary care. Psychosom Med. 2004;66:17–22.PubMedCrossRef
17.
Garcia-Cebrian A, Bauer M, Montejo AL, et al. Factors influencing depression endpoints research (FINDER): study design and population characteristics. Eur Psychiatry. 2008;23:57–65.PubMedCrossRef
18.
Bauer M, Monz BU, Montejo AL, et al. Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study. Eur Psychiatry. 2008;23:66–73.PubMedCrossRef
19.
Reed C, Monz BU, Perahia DGS, et al. Quality of life outcomes among patients with depression after 6 months of starting treatment: results from FINDER. J Affect Disord. 2009;113:296–302.PubMedCrossRef
20.
21.
Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–70.PubMedCrossRef
22.
Olsson I, Mykletun A, Dahl AA. The hospital anxiety and depression rating scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry. 2005;5:46.PubMedCentralPubMedCrossRef
23.
Goldstein DJ, Lu Y, Detke MJ, Hudson J, Iyengar S, Demitrack MA. Effects of duloxetine on painful physical symptoms associated with depression. Psychosomatics. 2004;45:17–28.PubMedCrossRef
24.
Collins SL, Moore A, McQuay HJ. The visual analogue pain intensity scale: what is moderate pain in millimetres? Pain. 1997;72:95–7.PubMedCrossRef
25.
Ware JE Jr., Kosinski M, Keller SD. SF-36 Physical and mental health summary scales: a user’s manual. Boston: Health Assessment Laboratory, New England Medical Center; 1994:8:21; 8:29.
26.
Kind P, Hardman G, Macran S. UK Population norms for EQ-5D. York Centre for Health Economics Discussion Paper 172; 1999.
27.
Daly EJ, Trivedi MH, Wisniewski SR, et al. Health-related quality of life in depression: a STAR*D report. Ann Clin Psychiatry. 2010;22:43–55.PubMed
28.
Munoz RA, McBride ME, Brnabic AJ, et al. Major depressive disorder in Latin America: the relationship between depression severity, painful somatic symptoms and quality of life. J Affect Disord. 2005;86:93–8.PubMedCrossRef
29.
Garcia-Campayo J, Ayuso-Mateos JL, Caballero L, et al. Relationship of somatic symptoms with depression severity, quality of life, and health resources utilization in patients with major depressive disorder seeking health care in Spain. Prim Care Companion J Clin Psychiatry. 2008;10:355–62.PubMedCentralPubMedCrossRef
30.
Demyttenaere K, Reed C, Quail D, et al. Presence and predictors of pain in depression: results from the FINDER study. J Aff Disord. 2010 (Epub ahead of print).
31.
Bair MJ, Robinson RJ, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003;163:2433–45.PubMedCrossRef
32.
Sapin C, Fantino B, Nowicki ML, Kind P. Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder. Health Qual Life Outcomes. 2004;2:20.PubMedCentralPubMedCrossRef
33.
Sobocki P, Ekman M, Ågren H, et al. Health-related quality of life measured with EQ-5D in patients treated for depression in primary care. Value Health. 2007;10:153–60.PubMedCrossRef
34.
Kelly AM. The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain. Emerg Med J. 2001;18:205–7.PubMedCentralPubMedCrossRef
35.
36.
Leuchter AF, Husain MM, Cook IA, et al. Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report. Psychol Med. 2010;40:239–51.PubMedCrossRef
37.
38.
Kendrick T, Chatwin J, Dowrick C, et al. Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) study. Health Technology Assessment. 2009;13:iii–iv, ix–xi, 1–159.
Metadata
Title
Quality of Life in Depressed Patients in UK Primary Care: The FINDER Study
Authors
Alan Lenox-Smith
Mark T. B. Macdonald
Catherine Reed
Andre Tylee
Robert Peveler
Deborah Quail
Hiram J. Wildgust
Publication date
01-12-2013
Publisher
Springer Healthcare
Published in
Neurology and Therapy / Issue 1-2/2013
Print ISSN: 2193-8253
Electronic ISSN: 2193-6536
DOI
https://doi.org/10.1007/s40120-013-0006-1

Other articles of this Issue 1-2/2013

Neurology and Therapy 1-2/2013 Go to the issue

Review

Perampanel: What is its Place in the Management of Partial Onset Epilepsy?

ORIGINAL RESEARCH

Social Characteristics and Quality of Life of Portuguese Multiple Sclerosis Patients

Case Report

Childhood Absence Epilepsy Successfully Treated with the Paleolithic Ketogenic Diet

Case Report

Bilateral Acute Angle-Closure Glaucoma Following Treatment with Topiramate for Headache

Case Report

Listeria monocytogenes Meningoencephalitis Mimicking Stroke in a Patient with Chronic Lymphocytic Leukemia

Review

A Review of the Social, Psychological, and Economic Burdens Experienced by People with Spina Bifida and Their Caregivers